Agilysys (AGYS)
(Delayed Data from NSDQ)
$114.90 USD
+2.39 (2.12%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $114.91 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$114.90 USD
+2.39 (2.12%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $114.91 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Will Agilysys (AGYS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed at $17.49 in the latest trading session, marking a +0.75% move from the prior day.
Agilysys (AGYS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed the most recent trading day at $23.89, moving +0.89% from the previous trading session.
Agilysys (AGYS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Agilysys (AGYS) closed at $19.23, marking a -1.03% move from the previous day.
Agilysys (AGYS) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of -866.67% and -1.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Agilysys (AGYS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Agilysys (AGYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilysys (AGYS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Agilysys (AGYS) closed the most recent trading day at $18.23, moving -0.33% from the previous trading session.
Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: Agilysys (AGYS)
by Brian Bolan
If you are looking for a stock that has not seen that much of a bounce in the early days of the recovery be sure to read this.
Agilysys Enters Oversold Territory
by Zacks Equity Research
Agilysys has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
New Strong Buy Stocks for March 19th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today.
Is Agilysys (AGYS) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Is (AGYS) Outperforming Other Computer and Technology Stocks This Year?
5 Top-Ranked Nasdaq Stocks That Have Skyrocketed YTD
by Nalak Das
Although three major stock indexes posted single-digit gains so far this year, several Nasdaq Composite stocks have surged more than 30%.
Computer Integrated Systems Industry Boasts Bright Prospects
by Zacks Equity Research
The Zacks Computer Integrated Systems industry is benefiting from increasing demand across small, medium and large-scale enterprises and investments in IoT, AI and blockchain software technologies.
The Zacks Analyst Blog Highlights: AGYS, SLM, FRTA, MSFT and TROW
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AGYS, SLM, FRTA, MSFT and TROW
The Zacks Analyst Blog Highlights: Agilysys, Masonite, SPX and Simply Good Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Agilysys, Masonite, SPX and Simply Good Foods
Forget Coronavirus: 5 Must-Buy Nasdaq Stocks to Tap Rally
by Nalak Das
Despite coronavirus-led pullback, the Nasdaq Composite Index gained impressively in January.
U.S. Manufacturing Showing Signs of Bottoming Out: 5 Top Picks
by Nalak Das
U.S. Manufacturing likely to benefit from the phase-one trade deal signed by the United States and China.
The Zacks Analyst Blog Highlights: Agilysys, Tandem Diabetes Care, Enphase Energy, Forterra and MagnaChip Semiconductor
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Agilysys, Tandem Diabetes Care, Enphase Energy, Forterra and MagnaChip Semiconductor
5 Top-Ranked Growth Stocks for February That Have Jumped YTD
by Nalak Das
Several positive factors have strengthened investors' confidence in risky assets like equities. A few top-ranked growth stocks surged in January and still have strong upside left.
Top Ranked Momentum Stocks to Buy for January 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 30th.
Will Agilysys Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Agilysys.
Top Ranked Momentum Stocks to Buy for January 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 29th
New Strong Buy Stocks for January 29th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Agilysys (AGYS) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of -37.50% and 2.68%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?